31
Active Trials
6
Phase 1
3
Phase 2
23
Phase 3
7
Therapeutic Areas
Portfolio Concentration: 77% of active trials in Immunology
Immunology
24 active / 64 total
Rheumatoid Arthritis
9 active
7 Ph3
21 total since 2015
Psoriatic Arthritis
6 active
4 Ph3
13 total since 2015
Psoriasis
4 active
3 Ph3
17 total since 2015
Ankylosing Spondylitis
2 active
2 Ph3
5 total since 2015
Lupus
2 active
2 Ph3
3 total since 2015
Atopic Dermatitis
1 active
3 total since 2015
Crohn's Disease
0 active
2 total since 2015
CNS
6 active / 25 total
Musculoskeletal
3 active / 6 total
Urology
1 active / 1 total
Rare Disease
0 active / 4 total
Oncology
0 active / 3 total
Respiratory
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)